Refresher Course: Cardiac

RC 703 - Imaging challenging cardiomyopathies

February 27, 08:30 - 09:30 CET

5 min
Chairperson's introduction
Maja Hrabak Paar, Zagreb / Croatia
  1. To understand the fundamentals of arrhythmogenic ventricular cardiomyopathy (AVC) and its clinical significance, including the associated risk factors and diagnostic challenges.
  2. To examine the PADUA criteria, a novel classification system for diagnosing AVC based on CMR findings, and learn how to apply these criteria in clinical practice for an accurate and standardised evaluation.
  3. To discuss the clinical implications of using CMR and the PADUA criteria in diagnosing and managing AVC, including their impact on risk stratification, treatment planning, and patient outcomes.
15 min
New horizons for imaging cardiomyopathies
Declan O'Regan, London / United Kingdom
  1. To understand the principles of CMR image analysis in cardiomyopathy.
  2. To appreciate the role of new imaging techniques in diagnosing cardiomyopathy.
  3. To learn the future role of AI in assessing cardiomyopathy.
15 min
Arrhythmogenic ventricular cardiomyopathy in the light of the PADUA criteria
Rodrigo Salgado, Antwerpen / Belgium
  1. To understand the fundamentals of Arrhythmogenic Ventricular Cardiomyopathy (AVC) and its clinical significance, including the associated risk factors and diagnostic challenges.
  2. To examine the PADUA criteria, a novel classification system for diagnosing AVC based on CMR findings, and learn how to apply these criteria in clinical practice for an accurate and standardised evaluation.
  3. To discuss the clinical implications of using CMR and the PADUA criteria in diagnosing and managing AVC, including their impact on risk stratification, treatment planning, and patient outcomes.
15 min
Left ventricular hypertrabeculation/non-compaction: drop cardiomyopathy, think heterogenous phenotype
Tim Leiner, Rochester / United States
  1. To understand the phenotypic description of left ventricular hypertrabeculation.
  2. To learn criteria to describe left ventricular hypertrabeculation.
  3. To discuss the clinical relevance of left ventricular hypertrabeculation on the patient's clinical management.
10 min
Panel discussion: How to recognise and approach non-ischaemic cardiomyopathies